Dan-Feng Mei is an associate in the New York office  and practices primarily in the firm's Intellectual Property, Patent Litigation and IP Counseling & Due Diligence Groups. Dan-Feng’s practice involves patent litigation and counseling in the pharmaceutical and biotechnology industries, focusing on litigation of patent infringement suits arising under Section 505(j) of the Federal Food, Drug and Cosmetic Act (Hatch-Waxman).

Professional Activities

• New York State Bar Association (Intellectual Property Law Section Fellow –
• 2010-2012)
• American Bar Association

Honors

• Ruth Whitehead Whaley Scholar (2010-2011)
• Dean’s List (2008-2009) and (2010-2011)
• CALI Award for Excellence in Contracts I and Property II

News

• Federal Circuit Rules for Axinn Client in Abilify Patent Appeal
• Axinn Obtains Stipulated Summary Judgment of Non-Infringement for Zydus
• Axinn Successfully Obtains Dismissal for Zydus Pharmaceuticals
• Axinn Obtains Denial of a TRO Motion for Client Zydus

Thought Leadership

• Patent Law for the Dermatologist, Seminars in Cutaneous Medicine and Surgery
• Formulation Patents and Dermatology and Obviousness, Pharmaceutics, November 21, 2011

Education

• JD – Fordham School of Law (2012)
• St. John's School of Law (2008-2009)
• BA, Neuroscience and Behavior – Barnard College (2004)

Admissions

• New York
• New Jersey
• US District Court District of New Jersey
• US Patent and Trademark Office